quinazolines has been researched along with Ebola Hemorrhagic Fever in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bekerman, E; Einav, S | 1 |
Adhikary, S; Davey, RA; Garver, J; Johnson, L; Kolokoltsov, AA; Vela, EM | 1 |
2 other study(ies) available for quinazolines and Ebola Hemorrhagic Fever
Article | Year |
---|---|
Infectious disease. Combating emerging viral threats.
Topics: Adenine; Adenosine; Antiviral Agents; Benzamides; Chloroquine; Communicable Diseases, Emerging; Cyclosporins; Cytosine; Dengue; Drug Approval; Drug Design; Erlotinib Hydrochloride; Hemorrhagic Fever, Ebola; Humans; Imatinib Mesylate; Indoles; Organophosphonates; Piperazines; Purine Nucleosides; Pyrimidines; Pyrroles; Pyrrolidines; Quinazolines; Sunitinib; Viruses | 2015 |
Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin.
Topics: Antiviral Agents; Cell Line; Ebolavirus; Genistein; Hemorrhagic Fever, Ebola; Humans; Lassa Fever; Lassa virus; Protein Kinase Inhibitors; Quinazolines; Tyrphostins | 2012 |